Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharma 4.0 Continuous mRNA Drug Products Manufacturing
Andreas Ouranidis, Christina Davidopoulou, Reald-Konstantinos Tashi, et al.
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1371-1371
Open Access | Times Cited: 25

Showing 25 citing articles:

Quality by Design for enabling RNA platform production processes
Simon Daniel, Zoltán Kis, Cleo Kontoravdi, et al.
Trends in biotechnology (2022) Vol. 40, Iss. 10, pp. 1213-1228
Open Access | Times Cited: 75
mRNA in the Context of Protein Replacement Therapy
Theofanis Vavilis, Εleni Stamoula, Alexandra Ainatzoglou, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 166-166
Open Access | Times Cited: 64
mRNA vaccines: the most recent clinical applications of synthetic mRNA
Suji Kwon, Minseon Kwon, Seongeun Im, et al.
Archives of Pharmacal Research (2022) Vol. 45, Iss. 4, pp. 245-262
Open Access | Times Cited: 50
Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach
Ravi Maharjan, Shavron Hada, Ji‐Eun Lee, et al.
International Journal of Pharmaceutics (2023) Vol. 640, pp. 123012-123012
Closed Access | Times Cited: 23
Membrane technology for the purification of RNA and DNA therapeutics
Amin Javidanbardan, Kevork Oliver Messerian, Andrew L. Zydney
Trends in biotechnology (2024) Vol. 42, Iss. 6, pp. 714-727
Closed Access | Times Cited: 11
mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles
Andreas Ouranidis, Theofanis Vavilis, Evdokia Mandala, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 50-50
Open Access | Times Cited: 46
Increasing yield of in vitro transcription reaction with at‐line high pressure liquid chromatography monitoring
Domen Pregeljc, Janja Skok, Tina Vodopivec, et al.
Biotechnology and Bioengineering (2022) Vol. 120, Iss. 3, pp. 737-747
Open Access | Times Cited: 29
Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing
Maryam Youssef, Cynthia Hitti, Julia Puppin Chaves Fulber, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1497-1497
Open Access | Times Cited: 17
Purification of linearized template plasmid DNA decreases double-stranded RNA formation during IVT reaction
Juan Carlos Martı́nez, Verónica Lampaya, Ana Larraga, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 16
Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches
Ravi Maharjan, Ki Hyun Kim, Kyeong Lee, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 11, pp. 100996-100996
Open Access | Times Cited: 7
Recent Advances and Innovations in the Preparation and Purification of In Vitro-Transcribed-mRNA-Based Molecules
Jingjing Zhang, Yuheng Liu, Chao Li, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2182-2182
Open Access | Times Cited: 15
Technical Considerations for the Conformation of Specific Competences in Mechatronic Engineers in the Context of Industry 4.0 and 5.0
Eusebio Jiménez López, Francisco Cuenca Jiménez, Gabriel Luna Sandoval, et al.
Processes (2022) Vol. 10, Iss. 8, pp. 1445-1445
Open Access | Times Cited: 19
Scalable mRNA Machine for Regulatory Approval of Variable Scale between 1000 Clinical Doses to 10 Million Manufacturing Scale Doses
Alina Hengelbrock, A. Schmidt, Heribert Helgers, et al.
Processes (2023) Vol. 11, Iss. 3, pp. 745-745
Open Access | Times Cited: 9
Digital Twin Fundamentals of mRNA In Vitro Transcription in Variable Scale Toward Autonomous Operation
Alina Hengelbrock, A. Schmidt, Jochen Strube
ACS Omega (2024)
Open Access | Times Cited: 2
Maximizing the mRNA productivity for in vitro transcription by optimization of fed-batch strategy
Letao Guo, Zhikai Liu, Shirong Song, et al.
Biochemical Engineering Journal (2024) Vol. 210, pp. 109412-109412
Closed Access | Times Cited: 2
Microfluidic Bioreactor with Fibrous Micromixers for In Vitro mRNA Transcription
Inseong Choi, Guk‐Young Ahn, Eun Seo Kim, et al.
Nano Letters (2023) Vol. 23, Iss. 17, pp. 7897-7905
Closed Access | Times Cited: 6
Pharma 4.0-Artificially Intelligent Digital Twins for Solidified Nanosuspensions
Christina Davidopoulou, Andreas Ouranidis
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2113-2113
Open Access | Times Cited: 8
Computational Pharmaceutics: A Comprehensive Review of Past Achievements, Present Applications, and Future Challenges
Yogesh Chaudhari, Manisha Chaudhari, Abhijeet Puri, et al.
(2024)
Open Access | Times Cited: 1
COMPARING vaccine manufacturing technologies recombinant DNA vs in vitro transcribed (IVT) mRNA
Christina Davidopoulou, Dimitrios Kouvelas, Andreas Ouranidis
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Long Non-Coding RNAs Might Regulate Phenotypic Switch of Vascular Smooth Muscle Cells Acting as ceRNA: Implications for In-Stent Restenosis
Alberto Arencibia, Fernando Laņas, Luis A. Salazar
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3074-3074
Open Access | Times Cited: 7
Recombinant Protein Technology in the Challenging Era of Coronaviruses
Ace Bryan Sotelo Cabal, Tzong‐Yuan Wu
Processes (2022) Vol. 10, Iss. 5, pp. 946-946
Open Access | Times Cited: 7
Computational Pharmaceutics: A Comprehensive Review of Past Achievements, Present Applications, and Future Challenges
Yogesh Chaudhari, Manisha Chaudhari, Abhijeet Puri, et al.
(2024)
Open Access
Good Manufacturing Practices and Upscaling of mRNA Vaccine Production
Εleni Stamoula, Theofanis Vavilis, Ioannis Dardalas, et al.
(2024), pp. 177-200
Closed Access
Establishment of a semi-continuous nano-production line using the Microfluidizer® technology for the fabrication of lipid-based nanoparticles part 1: Screening of critical parameters and Design of Experiment optimization studies
Christina Glader, Ramona Jeitler, Yan Wang, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 203, pp. 106928-106928
Open Access
Effects of exercise interventions on cancer-related fatigue in breast cancer patients: An overview of systematic reviews
Hong-Juan Zhou, Tao Wang, Yong‐Zhi Xu, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Page 1

Scroll to top